Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000919574-26-000953·SUTRO BIOPHARMA, INC.
Schedule 13G ownership disclosure
SUTRO BIOPHARMA INC
Common Stock, $0.001 par value · CUSIP: 869367102
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SUVRETTA CAPITAL MANAGEMENT, LLC
Shares: 0.00 · Class: 0%
- AVERILL MASTER FUND, LTD.
Shares: 0.00 · Class: 0%
- AARON COWEN
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-26-000953
- Form type
- SCHEDULE 13G/A
- Filer
- SUTRO BIOPHARMA, INC.
- CIK
- CIK 1382101
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership